acquired
Stage
1
Investors
About
Swift Biosciences developed next-generation sequencing (NGS) library preparation kits and reagents focused on research and clinical genomics applications. The company was acquired by Integrated DNA Technologies in March 2021.
Explore Swift Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.